Read news on cystic fibrosis with our app.
Read more in the app
Researchers disable antimicrobial resistance in cystic fibrosis-associated bacteria - EurekAlert!
Why inflammation persists in cystic fibrosis—even after CFTR correction - EurekAlert!
A fundamentally new therapeutic approach to cystic fibrosis: Nanobody repairs cellular defect - EurekAlert!
For scientists, cystic fibrosis was a medical mystery no one could solve. For patients, waiting was its own kind of suffering.
Engineers sharpen gene-editing tools to target cystic fibrosis - EurekAlert!
Smart nanoparticles launch genetic attack on lung cancer and cystic fibrosis
New genetic delivery system targets lungs to treat cancer, cystic fibrosis - EurekAlert!
Guideline on newborn screening for cystic fibrosis calls for changes in practice
First guideline on newborn screening for cystic fibrosis calls for changes in practice to improve outcomes - EurekAlert!
Stalled microbiomes: Cystic fibrosis disrupts early gut development in infants
Cystic fibrosis damages the immune system early on
Mental health challenges faced by children with cystic fibrosis are the focus of a major, multisite study led by UB - EurekAlert
Leukocyte telomere length and disease severity in cystic fibrosis - EurekAlert
SP-101 is a novel AAV gene therapy for cystic fibrosis - EurekAlert
How an emerging disease in dogs is shedding light on cystic fibrosis
Cystic fibrosis: School-aged children benefit from triple combination therapy - EurekAlert
Cystic fibrosis: School-aged children benefit from triple combination therapy
Lung-targeted CRISPR therapy offers hope for cystic fibrosis
Landmark study involving babies in Ireland supports use of Cystic Fibrosis drug in infants from four weeks of age - EurekAlert
Landmark study involving babies in Ireland supports use of Cystic Fibrosis drug in infants from four weeks of age
